Clinical Trials in Arizona

Showing 10861-10880 of 16,770 trials

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

NCT02991430

This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.

Scion NeuroStim45 participantsStarted Jun 2017

Scottsdale, Arizona, United States • West Palm Beach, Florida, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPhase 331 miles

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

NCT01763918

The primary objective was to evaluate the effect of 12 weeks of evolocumab subcutaneously once every 2 weeks (Q2W) and once monthly (QM), compared with placebo, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in adults with heterozygous familial hypercholesterolemia (HeFH).

Hyperlipidemia

Amgen331 participantsStarted Feb 2013

Scottsdale, Arizona, United States • Cincinnati, Ohio, United States • Camperdown, New South Wales, Australia +36 more locations

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Find Trials by Condition in Arizona

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Food Effect Study of CTP-543 in Healthy Volunteers

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

National Prevalence and Impact of Noninvasive Prenatal Testing

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Genetic Assessment of Early to Late Macular Degeneration Study

Assessing Superion Clinical Endpoints vs. Decompression

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency